HOME >> BIOLOGY >> NEWS
Cornell scientists link E. coli bacteria to Crohn's disease

ITHACA, N.Y. A team of Cornell University scientists from the College of Veterinary Medicine, Weill Cornell Medical College and the College of Agriculture and Life Sciences have discovered that a novel group of E. coli bacteria containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague is associated with intestinal inflammation in patients with Crohns disease in their research paper published July 12 by The ISME Journal: Multidisciplinary Journal of Microbial Ecology.

Crohns disease, an incurable inflammatory disorder of the intestine most commonly found in the lower part of the small intestine called the ileum affects 1-in-1,000 people in Europe and North America. Thus far, gut bacteria have long been suspected in playing a pivotal role in the development of Crohns disease, but the specific bacterial characteristics that drive the inflammatory response have remained elusive.

Researchers at Cornell examined possible causes for the disease in patients with Crohns restricted to the ileum and the colon versus healthy individuals.

Given that only about 20 percent of fecal bacteria can be cultured, our group adopted a broad culture-independent approach to target specific subgroups of bacteria for quantitative in situ analysis and culture based characterization, said Kenneth Simpson, professor of small animal medicine at the College of Veterinary Medicine. Our findings raise the possibility that a novel group of E. coli contains opportunistic pathogens that may be causally related to chronic intestinal inflammation in susceptible individuals. They suggest that an integrated approach that considers an individuals mucosa-associated flora in addition to disease phenotype and genotype may improve outcome.

The study found an increased level of E. coli bacteria in more inflamed areas of the small intestines instead of MAP, a bacterium related
'"/>

Contact: Sabina Lee
ssl37@cornell.edu
607-255-3024
Cornell University News Service
7-Aug-2007


Page: 1 2

Related biology news :

1. Weill Cornell team identifies potential new cancer drug target
2. Methodist, University of Houston, Cornell combine biomedical imaging expertise
3. Weill Cornell pharmacologist receives prestigious NIH MERIT Award
4. Cornell lab confirms deadly fish virus spreading to new species
5. NSF awards $3.3 million grant to Cornell to bolster the percentage of women faculty members
6. Cornell researchers find serious fish virus in Northeast for first time
7. Cornell finds natural selection in humans
8. Northeast Sun Grant Institute at Cornell spurs green revolution
9. Stem cell research at Weill Cornell, The Rockefeller University, and Sloan-Kettering
10. Cornell graduate student named 2005 AIBS Emerging Public Policy Leader
11. Weill Cornell team develops fast-acting anthrax vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... ... , ... PureWay, a healthcare-focused provider of sharps disposal, biohazard ... of sales and business development efforts, effective immediately. Mr. Kennedy will report directly ... Johnson & Johnson Medical, Globus Medical, WRP Asia Pacific, and Stryker, all where ...
(Date:1/7/2019)... ... January 07, 2019 , ... Concerto HealthAI, a ... precision health in oncology and other key therapeutic areas, and its Chief Executive ... entrepreneurs and executives spanning the entire healthcare landscape, on January 8, 2019, at ...
(Date:1/5/2019)... ... 04, 2019 , ... Join Bill Fox, Chief Strategy Officer, ... from MarkLogic – for a live webinar on Wednesday, January 16, ... using real world data for pharmacovigilance, and the implications of current inefficient data ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... , ... January 11, 2019 , ... Drawing on over ... Tuesday, January 22, 2019 at 2:30pm EST will explore some of the key lessons ... of using one vendor vs. using multiple vendors, and find out how to ensure ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... into Noninvasix. This represents the second investment AngelMD has made into Noninvasix in ... Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure brain ...
(Date:1/4/2019)... , ... January 01, 2019 , ... ... Microbiome Conference at the World Economic Forum Annual Meeting January 22-25, 2019 held ... is invitation-only. , The World Economic Forum Annual Meeting brings together leaders of ...
(Date:12/19/2018)... ... December 19, 2018 , ... R3 Stem Cell is ... Training Course in Las Vegas. Training includes facial rejuvenation, hair restoration and erectile ... nationwide for aesthetics, having the training from expert, Board Certified providers is critical ...
Breaking Biology Technology:
Cached News: